Literature DB >> 7082540

The effect of the beta-adrenoceptor antagonist pindolol on exercise performance.

R C Dhatariya, A J Blowers.   

Abstract

1 Fifty-two patients who had been treated for essential hypertension for at least 5 years with once-a-day pindolol alone or in combination with a diuretic participated in a strenuous exercise programme. The 24 h antihypertensive efficacy of once-a-day pindolol was shown in blood pressure readings made before the intake of the day's dose. 2 During the first stage of the study before interruption of therapy, pindolol maintained effective blood pressure control and prevented an excessive rise in blood pressure and heart rate following strenuous exercise. 3 Following a 6 week period of interruption of pindolol therapy, higher blood pressure and heart rate levels were reached following exercise. 4 After reintroduction of a single dose of pindolol, improvement in blood pressure control and lower heart rate levels were again seen following exercise. 5 Compared with the period without drug systolic and diastolic blood pressures were lowered to about the same extent at rest and during exercise after maintenance pindolol and after a single dose of pindolol following a 6 week interruption period, but pre-exercise levels rose considerably during the period when therapy was discontinued.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082540      PMCID: PMC1402071          DOI: 10.1111/j.1365-2125.1982.tb01443.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

Review 1.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

2.  Pindolol, (Visken, LB46). A new treatment for hypertension: report of a multicentric open study.

Authors:  I S Collins; I W King
Journal:  Curr Ther Res Clin Exp       Date:  1972-04

3.  Antihypertensive effects of pindolol in patients on diuretics.

Authors:  R C Dhatariya
Journal:  Practitioner       Date:  1977-04

4.  An assessment of pindolol in the general practice management of hypertension.

Authors:  D J Davies
Journal:  Br J Clin Pract       Date:  1976-10

5.  Present state of alpha and beta adrenergic drugs III. Beta blocking agents.

Authors:  R P Ahlquist
Journal:  Am Heart J       Date:  1977-01       Impact factor: 4.749

6.  Once daily administration of pindolol in the treatment of hypertension.

Authors:  R C Dhatariya; A J Blowers
Journal:  J Int Med Res       Date:  1977       Impact factor: 1.671

7.  beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

8.  Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man.

Authors:  R C Hill; P Turner
Journal:  Br J Pharmacol       Date:  1969-06       Impact factor: 8.739

9.  The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix).

Authors:  I Persson
Journal:  Eur J Clin Pharmacol       Date:  1977-07-19       Impact factor: 2.953

10.  Increased plasma noradrenaline concentrations in essential hypertension and their decrease after long-term treatment with a beta-receptor-blocking agent (prindolol).

Authors:  H M Brecht; F Banthien; W Ernst; W Schoeppe
Journal:  Clin Sci Mol Med Suppl       Date:  1976-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.